THU0104 Both MRI and HAQ-DI can predict relapses following all treatment withdrawal in MTX-NAÏVE patients with RA in remission after 12 months of abatacept therapy in the avert trial

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning